KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $577.0 million.

  • Amgen's Other Working Capital Changes rose 402142.86% to $577.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year increase of 9432.52%. This contributed to the annual value of $1.3 billion for FY2025, which is 9432.52% up from last year.
  • Amgen's Other Working Capital Changes amounted to $577.0 million in Q4 2025, which was up 402142.86% from $283.0 million recorded in Q3 2025.
  • In the past 5 years, Amgen's Other Working Capital Changes registered a high of $577.0 million during Q4 2025, and its lowest value of -$241.0 million during Q2 2022.
  • Moreover, its 5-year median value for Other Working Capital Changes was $127.0 million (2021), whereas its average is $123.1 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 31517.86% in 2022, then surged by 402142.86% in 2025.
  • Quarter analysis of 5 years shows Amgen's Other Working Capital Changes stood at -$136.0 million in 2021, then soared by 32.35% to -$92.0 million in 2022, then surged by 352.17% to $232.0 million in 2023, then tumbled by 93.97% to $14.0 million in 2024, then soared by 4021.43% to $577.0 million in 2025.
  • Its last three reported values are $577.0 million in Q4 2025, $283.0 million for Q3 2025, and $206.0 million during Q2 2025.